Cervicouterine Cancer Screening – TruScreen™ vs. Conventional Cytology: Pilot Study

INTRODUCTION: Cervicouterine cancer (CC) is a health problem worldwide and is the fourth most common cancer in women, with a greater proportion of individuals affected by advanced stages of the disease in developing countries. OBJECTIVE: To determine the sensitivity and specificity of the TruScreen™...

Descripción completa

Detalles Bibliográficos
Autores principales: Salazar-Campos, J. E., González-Enciso, A., Díaz-Molina, R., Lara-Hernández, M. E., Coronel-Martínez, J., Pérez-Plasencia, C., de León, D. Cantú
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060572/
https://www.ncbi.nlm.nih.gov/pubmed/30089942
http://dx.doi.org/10.4103/JOC.JOC_111_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060572/
https://www.ncbi.nlm.nih.gov/pubmed/30089942
http://dx.doi.org/10.4103/JOC.JOC_111_17

Ejemplares similares